Related Experiment Video
Updated: Apr 28, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Medical therapy for uveal effusion syndrome
B Andrijević Derk1, G Benčić1, V Corluka2
1University Clinical Centre 'Sestre milosrdnice', University Department of Ophthalmology, Zagreb, Croatia.
Conservative medical therapy, including carbonic anhydrase inhibitors and prostaglandin analogues, showed apparent resolution of chorioretinal detachment in two of three patients with bilateral uveal effusion syndrome.
Area of Science:
- Ophthalmology
- Medical research
Background:
- Bilateral uveal effusion syndrome (UES) typically requires surgical intervention.
- Limited data exists on conservative management strategies for UES.
Observation:
- A case series of three patients with bilateral UES was analyzed.
- Patients received conservative treatment with oral carbonic anhydrase inhibitors and topical prostaglandin analogues.
Findings:
- Two out of three patients achieved resolution of chorioretinal detachment within 3 months using medical therapy alone.
- One patient required surgical intervention.
- Recurrence-free follow-up was observed in all patients.
Implications:
- Conservative medical management may be a viable first-line approach for bilateral UES.
- Further research is needed to validate the efficacy of this therapeutic strategy compared to surgical options.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
Nephrotic Syndrome II : Assessment and Medical Management
Glaucoma: Overview
Venous Thrombosis III: Interprofessional Care

